Kura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research note published on Monday, Benzinga reports. HC Wainwright currently has a $32.00 target price on the stock. Several other research firms have also weighed in on KURA. StockNews.com lowered Kura Oncology from a hold rating to a […]